Emerging Therapies for IgG4-Related Disease
Dr. Matthew Baker provides an update on emerging therapies for IgG4-Related Disease (IgG4-RD), discussing B and T cell pathogenesis, the limitations of steroid treatments, and the use of rituximab. The episode also examines the promising results of the Mitigate Trial.